NICE has recommended further evidence generation for the Genedrive MT-RNR1 ID Kit, a technology developed to detect a genetic variant that guides antibiotic use and prevents hearing loss in babies.
This plan outlines the gaps in evidence for the technology and the real-world data that needs to be collected for a future NICE review. The responsibility for data collection and analysis lies with the technology developer.
Support for evidence generation will be facilitated by the Office for Life Sciences, pending business case approval. This includes funding for evidence generation consortia, bringing together analytical partners, implementation sites, and developers.
Guidance on commissioning and procurement of the technology will be provided by NHS England, who is also developing a digital health technology policy framework.
After 3 years of evidence generation, the developer should submit the evidence to NICE for review and decision making on routine adoption in the NHS.
🌟 Embracing technology for elderly care is essential in enhancing health and independence. Discover how smart home technologies, wearable devices, and telehealth services are shifting elderly care. Let’s create a supportive environment for our ageing population.
#SyenzaNews #ElderlyCare #AIInHealthcare #HealthTech #Telehealth #WearableTech #SmartHome 🌐
Learn more about the latest innovations in elderly care and how they can improve the quality of life for older adults.
🌍📈 The elderly population in Sub-Saharan Africa is set to triple by 2050, presenting unique healthcare challenges. Our latest article explores the current policy environment, healthcare needs, and future directions for effective policymaking. Let’s ensure our ageing population receives the care and support they deserve. Read more on our website! #SyenzaNews #Healthcare #AgingPopulation #SubSaharanAfrica #PolicyResearch 🌟
🔍 Explore the latest insights on dementia risk factors in the UK! Unveiling trends, disparities, and strategies for effective prevention. Let’s work towards a healthier future together!
#SyenzaNews #HealthcareUK #DementiaResearch #PreventDementia #ResearchInsights 🧠
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
